Evidence-Based Haemostasis
S Karger AG (Verlag)
978-3-8055-7418-1 (ISBN)
- Titel leider nicht mehr lieferbar
- Artikel merken
Disease Transmission by Blood Products - Past, Present and Future, W.G. Murphy; The Evidence behind Inhibitor Treatment with Porcine Factor VIII, C.A. Lee; Evidence for the Use of Activated Prothrombin Complex Concentrates (aPCCs) in the Treatment of Patients with Haemophilia and Inhibitors, J.T. Wilde; The Evidence behind Inhibitor Treatment with Recombinant Factor VIIa, C.A. Ludlam; The 2000 United Kingdom Haemophilia Centre Doctors' Organisation (UKHCDO) Inhibitor Guidelines, C.R.M. Hay; Recombinant Factor VIIa in the Management of Surgery and Acute Bleeding Episodes in Children with Haemophilia and High-Responding Inhibitors, O.P. Smith; High Cost Patients and the Consortium Approach, S. Schonfield, K. Reid; Economic Impact of Treating Inhibitor Patients, L. Lacey; General Haemostatic Agents - Fact or Fiction?, U. Hedner; Treatment of Bleeding in Patients with Platelet Disorders - Is There a Place for Recombinant Factor VIIa?, Y. Laurian; The Use of Recombinant Factor VIIa in Controlling Surgical Bleeding in Non-Haemophiliac Patients, M. Aldouri; To General Haemostasis - the Evidence-Based Route, E. Erhardtsen.
| Zusatzinfo | 11 Tables |
|---|---|
| Verlagsort | Basel |
| Sprache | englisch |
| Gewicht | 210 g |
| Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Hämatologie |
| ISBN-10 | 3-8055-7418-5 / 3805574185 |
| ISBN-13 | 978-3-8055-7418-1 / 9783805574181 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
